|
Delayed
NSE India S.E.
03:00:12 15/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 77.00 INR | -9.09% |
|
-6.10% | -30.06% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||
Drugs And Chemicals | 59Cr | 62Cr | 83Cr | 103.97Cr | - | ||
Total Assets | 35Cr | 47Cr | 59Cr | 121.65Cr | - | ||
Interest Expense | -26.55L | -51.97L | -72.66L | -84.3L | - | ||
Income Tax Expense | 1.62Cr | 1.93Cr | 4.35Cr | 5.12Cr | - | ||
CAPEX | -1.93Cr | -3.07Cr | -93.99L | -3.47Cr | - | ||
EBT | 5.79Cr | 6.96Cr | 14Cr | 19Cr | - | ||
D&A | 46.03L | 54.98L | 56.78L | 63.6L | - | ||
Net Income | 4.17Cr | 5.03Cr | 10Cr | 14Cr | - |
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
India | 59Cr | 62Cr | 83Cr | 103.97Cr | - | ||
Total Assets | 35Cr | 47Cr | 59Cr | 121.65Cr | - | ||
Interest Expense | -26.55L | -51.97L | -72.66L | -84.3L | - | ||
Income Tax Expense | 1.62Cr | 1.93Cr | 4.35Cr | 5.12Cr | - | ||
D&A | 46.03L | 54.98L | 56.78L | 63.6L | - | ||
CAPEX | -1.93Cr | -3.07Cr | -93.99L | -3.47Cr | - | ||
Net Income | 4.17Cr | 5.03Cr | 10Cr | 14Cr | - | ||
EBT | 5.79Cr | 6.96Cr | 14Cr | 19Cr | - |
- Stock Market
- Stocks
- QUESTLAB Stock
- Financials Quest Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
